Stocks
Anika Therapeutics (ANIK) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2023 | 2023 | LTM ? | |||
| EBITDA, bln rub | ? | 2.62 | -4.91 | -18.4 | 2.52 | -11.2 | -50.6 | |
| Changes by years, y/y, % | -526% | -288% | +274% | -114% | -546% | |||
Anika Therapeutics. EBITDA US GAAP, bln rub
Anika Therapeutics. EBITDA US GAAP, changes, %
Anika Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Anika Therapeutics (ANIK) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 2.00 | -1.87 | 2.22 | -25.6 | -25.4 | -50.6 | |
| Changes by years, y/y, % | -130% | -79% | -2 840% | +519% | +515% | |||
| Changes by quarters, q/q, % | +1% | -194% | -219% | -1 252% | -1% | |||
